London, 10-11 October 2011: Pharmaceutical m-Health Conference
Creation Healthcare as the editor of the Healthcare Engagement Strategy e-journal is proud to have been selected as a media partner for the Pharmaceutical m-Health Conference, which takes place on the 10th and 11th of October 2011 in London, United Kingdom.
Here’s what the organizers are saying about the event:
This conference shall address the numerous ways in which the pharmaceutical industry specifically can contribute to, and benefit from the increasing mobility of healthcare. The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015*, and therefore represents a major opportunity.
The vast potential for mobile phones to change everyday life with their increasing technological capacity to connect people and systems over vast distances, send and receive larger amounts of information, and operate from ever more advanced platforms, affects people and businesses in a variety of ways. Healthcare is certainly no exception, and there are several areas of the pharmaceutical industry that are either undergoing fundamental changes to accommodate and gain from this mobility, or are about to.
*BCC Research, 2011
Key topics addressed:
Marketing, Sales and CRM: With e-marketing a now long established faucet of promotion, the difference that a mobile personalised service can offer is significant. The opportunities for personalised information delivered through a variety of interactive mediums and devices are ever increasing. In addition, the options that open up to reps in the field as a result of mobile technology are vast, and therefore merit thorough discussion as featured at this event.
Healthcare professionals and communication: How can pharma gain from the fact that a growing percentage of physicians not only own smart phones, but use them regularly in the workplace? Through mobile e-detailing and e-prescribing apps for example, knowledge about products are more easily accessible, as is feedback on those products.
Anti counterfeiting and developing markets: The pharmaceutical industry looses billions a year from counterfeited goods, and the toll this takes on the health of the patients that use them is made all the more shocking by the fact that developing nations are the most vulnerable to this crime. The increasing usage of mobiles in such countries means that information on how to spot such goods can reach far and wide, as can healthcare information in general.
Clinical trials: The possibilities to monitor patients from a distance via mobile connectivity are altering the way trials are conducted, as well as recruitment and retention. Self monitoring in chronic diseases has the potential to save an enormous amount each year.
Adherence: Improving patient adherence is of benefit to patients, healthcare professionals, and pharmaceutical companies themselves. The growing usage of mobile phones to issue medication reminders, and advise on the correct usage of pharmaceutical products, is therefore an exciting new outlet for improving adherence.
For more information about Pharmaceutical m-Health Conference in London, click here.